TRIM46 and nonpapillary renal cell carcinoma: KEGG assays revealed that TRIM46 and its partners were distinctly enriched in valine, leucine, and isoleucine degradation; fatty acid degradation; and glycerophospholipid metabolism (Figures 7D–F), suggesting that TRIM46 and its functional partners might influence ccRCC progression by regulating cell proliferation and substance metabolism.